Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    western regional Kundranda
Previous Study | Return to List | Next Study

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

This study has been terminated.
(PI Leaving Site)
Sponsor:
Information provided by (Responsible Party):
Western Regional Medical Center
ClinicalTrials.gov Identifier:
NCT01851174
First received: February 15, 2013
Last updated: February 27, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)